Chloroquine and Hydroxychloroquine: Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 November 2024

27 March 2024

  • curprev 20:0620:06, 27 March 2024‎ Lazy talk contribs‎ 4,218 bytes +2,016‎ No edit summary
  • curprev 20:0520:05, 27 March 2024‎ Lazy talk contribs‎ 2,202 bytes +2,202‎ Created page with " {{TreatmentInfo |drug_name=Chloroquine and Hydroxychloroquine |category=Repurposed Drugs |book_text=In aseries of studies conducted in Mexico City (23, 24, 25) patients received the traditional chemotherapy agent BCNU, with or without a 150 mg daily dose of chloroquine (the equivalent of 250 mg chloroquine phosphate). The results were that patients receiving chloroquine had a median survival time of 25-33 months, while those receiving BCNU alone had a median survival t..."
Retrieved from "http://glioblastomatreatments.wiki:80/index.php?title=Chloroquine_and_Hydroxychloroquine"